SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-259757
Filing Date
2022-10-11
Accepted
2022-10-07 19:15:35
Documents
17
Period of Report
2022-10-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d408269d8k.htm   iXBRL 8-K 46950
2 EX-99.1 d408269dex991.htm EX-99.1 116194
3 EX-99.2 d408269dex992.htm EX-99.2 18546
7 GRAPHIC g408269g1007214835677.jpg GRAPHIC 3587
8 GRAPHIC g408269g1008013030651.jpg GRAPHIC 1728
9 GRAPHIC g408269g1008013030860.jpg GRAPHIC 3049
  Complete submission text file 0001193125-22-259757.txt   340131

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zyme-20221007.xsd EX-101.SCH 2528
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20221007_lab.xml EX-101.LAB 18798
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20221007_pre.xml EX-101.PRE 11774
11 EXTRACTED XBRL INSTANCE DOCUMENT d408269d8k_htm.xml XML 3562
Mailing Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4
Business Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 221301816
SIC: 2834 Pharmaceutical Preparations